CLN8

gene product
C8orf61, EPMR, FLJ39417, TLCD6
This gene encodes a transmembrane protein belonging to a family of proteins containing TLC domains, which are postulated to function in lipid synthesis, transport, or sensing. The protein localizes to the endoplasmic reticulum (ER), and may recycle between the ER and ER-Golgi intermediate compartment. Mutations in this gene are associated with a disorder characterized by progressive epilepsy with cognitive disabilities (EPMR), which is a subtype of neuronal ceroid lipofuscinoses (NCL). Patients with mutations in this gene have altered levels of sphingolipid and phospholipids in the brain. [provided by RefSeq, Jul 2017]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
141 antibodies from 23 providers.

Antibody properties

General

Applications

or Cancel
Antibody
antibodies-online
48 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
NovoPro Bioscience Inc.
1 antibody
Biorbyt
11 antibodies
LifeSpan BioSciences, Inc.
23 antibodies
Invitrogen Antibodies
4 antibodies
Aviva Systems Biology
3 antibodies
Novus Biologicals
3 antibodies
GeneTex
2 antibodies
OriGene
2 antibodies
Abgent
1 antibody
ProSci
2 antibodies
Boster Biological Technology
1 antibody
Creative Biolabs
1 antibody
Creative Diagnostics
2 antibodies
MyBioSource
1 antibody
St John's Laboratory
1 antibody
United States Biological
13 antibodies
Leading Biology
1 antibody
Abbexa
2 antibodies
Sigma-Aldrich
2 antibodies
Abnova Corporation
1 antibody